Ambu A/S (OTCMKTS:AMBBY – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 900 shares, an increase of 350.0% from the September 30th total of 200 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is currently 2.3 days.
Ambu A/S Price Performance
Shares of AMBBY remained flat at $18.28 on Friday. The company has a current ratio of 2.52, a quick ratio of 1.51 and a debt-to-equity ratio of 0.09. The business’s 50 day simple moving average is $19.68 and its two-hundred day simple moving average is $18.90. The stock has a market capitalization of $4.30 billion and a P/E ratio of 91.40. Ambu A/S has a 52-week low of $9.45 and a 52-week high of $22.65.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $199.56 million for the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Read More
- Five stocks we like better than Ambu A/S
- Profitably Trade Stocks at 52-Week Highs
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Effectively Use the MarketBeat Ratings Screener
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Using the MarketBeat Dividend Tax Calculator
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.